| P2093 | author name string | Jianliu Wang | |
| | Zhiqi Wang | |
| | Yibo Dai | |
| P2860 | cites work | A comparison of disease recurrence between robotic versus laparotomy approach in patients with intermediate-risk endometrial cancer | Q92217019 |
| | Learning curve and surgical outcomes for laparoscopic surgery, including pelvic lymphadenectomy, for early stage endometrial cancer | Q92266251 |
| | Association of Radical Hysterectomy Surgical Volume and Survival for Early-Stage Cervical Cancer | Q92337991 |
| | Modify or abandon: minimally invasive radical hysterectomy for early-stage cervical cancer | Q92472389 |
| | Cancer statistics, 2020 | Q92488902 |
| | The impact of the surgical routes and learning curve of radical hysterectomy on the survival outcomes in stage IB cervical cancer: A retrospective cohort study | Q92907551 |
| | Targeting EZH2 in cancer | Q26769027 |
| | Integrated genomic characterization of endometrial carcinoma | Q28289962 |
| | Recurrence and Survival After Random Assignment to Laparoscopy Versus Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group LAP2 Study | Q30506479 |
| | Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks | Q34077139 |
| | Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2 | Q37411650 |
| | Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial | Q38378900 |
| | Treatment strategies for endometrial cancer: current practice and perspective. | Q38784346 |
| | Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study | Q39668107 |
| | Molecular insights into the classification of high-grade endometrial carcinoma | Q47301080 |
| | Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial | Q51759957 |
| | Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial | Q56112899 |
| | Endometrial cancer: Molecular markers and management of advanced stage disease | Q57163933 |
| | ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up | Q57903637 |
| | Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer | Q58090097 |
| | Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer | Q58090104 |
| | Surgical cytoreduction in stage IV endometrioid endometrial carcinoma | Q63199193 |
| | Clinical utility of pembrolizumab in the management of advanced solid tumors: an evidence-based review on the emerging new data. | Q64983989 |
| | Practice Bulletin No. 149: Endometrial cancer | Q86975171 |
| | Laparoscopic and abdominal hysterectomy are equivalent | Q87791034 |
| | Changes in Surgical Volume and Outcomes Over Time for Women Undergoing Hysterectomy for Endometrial Cancer | Q89062631 |
| | Advanced stage (IIIC/IV) endometrial cancer: Role of cytoreduction and determinants of survival | Q91032427 |
| | Does MMR status in endometrial cancer influence response to adjuvant therapy? | Q91259118 |
| P921 | main subject | microsatellite | Q265193 |
| | endometrial cancer | Q944777 |
| | minimally-invasive procedures | Q1755504 |
| | The Cancer Genome Atlas | Q3979425 |
| P577 | publication date | 2020-05-04 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: An analysis of the Cancer Genome Atlas data | |